Fezakinumab
Fezakinumab is an experimental drug that is being studied for the treatment of various autoimmune diseases. It is a human monoclonal antibody that targets the interleukin-22 (IL-22) protein, a cytokine involved in inflammatory responses.
Mechanism of Action
Fezakinumab works by binding to the IL-22 protein and preventing it from interacting with its receptor on the surface of cells. This blocks the signal that triggers inflammation, thereby reducing the symptoms of autoimmune diseases.
Clinical Trials
Fezakinumab has been tested in several clinical trials for conditions such as psoriasis, rheumatoid arthritis, and Crohn's disease. While results have been promising, further research is needed to determine the drug's long-term safety and efficacy.
Side Effects
As with any drug, fezakinumab may cause side effects. These can include nausea, headache, and injection site reactions. Patients should discuss potential side effects with their healthcare provider before starting treatment.
Future Research
Future research on fezakinumab will focus on determining the optimal dosing regimen, understanding how the drug works in different patient populations, and exploring its potential use in other autoimmune diseases.
See Also
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
